Setting risk-informed environmental standards for Bacillus anthracis spores

Risk Analysis : an Official Publication of the Society for Risk Analysis
Tao HongNicholas F Dudley Ward

Abstract

In many cases, human health risk from biological agents is associated with aerosol exposures. Because air concentrations decline rapidly after a release, it may be necessary to use concentrations found in other environmental media to infer future or past aerosol exposures. This article presents an approach for linking environmental concentrations of Bacillus. anthracis (B. anthracis) spores on walls, floors, ventilation system filters, and in human nasal passages with human health risk from exposure to B. anthracis spores. This approach is then used to calculate example values of risk-informed concentration standards for both retrospective risk mitigation (e.g., prophylactic antibiotics) and prospective risk mitigation (e.g., environmental clean up and reoccupancy). A large number of assumptions are required to calculate these values, and the resulting values have large uncertainties associated with them. The values calculated here suggest that documenting compliance with risks in the range of 10(-4) to 10(-6) would be challenging for small diameter (respirable) spore particles. For less stringent risk targets and for releases of larger diameter particles (which are less respirable and hence less hazardous), environmental sampl...Continue Reading

References

Nov 19, 1981·Nature·R J MancheeA J Stagg
Dec 10, 1999·American Journal of Infection Control·L L GibsonC N Haas
Oct 29, 2000·Risk Analysis : an Official Publication of the Society for Risk Analysis·P F Teunis, A H Havelaar
May 15, 2001·Environmental Science & Technology·K J HansenH O Johnson
Dec 19, 2001·Emerging Infectious Diseases·J A JerniganUNKNOWN Anthrax Bioterrorism Investigation Team
Jan 5, 2002·Environmental Science & Technology·P L GurianM J Schervish
Feb 8, 2002·Environmental Science & Technology·William J RileyWilliam W Nazaroff
May 23, 2002·International Journal of Hygiene and Environmental Health·Jacqueline Moya, Linda Phillips
Oct 25, 2002·Emerging Infectious Diseases·Carolyn M GreeneUNKNOWN CDC New Jersey Anthrax Investigation Team. Centers for Desease Control and Prevention
Oct 25, 2002·Emerging Infectious Diseases·Michael B HellerUNKNOWN New York City Anthrax Investigation Working Group
Oct 25, 2002·Emerging Infectious Diseases·Wayne T SandersonJohn H Bridges
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Christopher P WeisRobert Bull
Dec 4, 2003·Risk Analysis : an Official Publication of the Society for Risk Analysis·Vladimir P Reshetin, James L Regens
Jun 23, 2004·Emerging Infectious Diseases·Laura RoseMatthew J Srduino
Jul 8, 2005·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Dorothy A CanterCarlton J Kempter
Feb 24, 2006·Annals of Internal Medicine·Jon-Erik C HoltyDouglas K Owens
Nov 24, 2006·Applied and Environmental Microbiology·Gary S BrownTodd Rudolph
Dec 11, 2007·Applied and Environmental Microbiology·Ryan SinclairCharles P Gerba
Jun 17, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Timothy A BartrandCharles N Haas
Jun 28, 2008·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Margaret E ColemanStacey Massulik
Sep 17, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Louis Anthony Tony Cox, Douglas A Popken
Nov 11, 2008·Applied and Environmental Microbiology·Jason M EdmondsPeter A Emanuel
Nov 13, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·Louis Anthony Tony Cox
Feb 4, 2009·Risk Analysis : an Official Publication of the Society for Risk Analysis·Yin Huang, Charles N Haas
Mar 24, 2009·Journal of Applied Microbiology·Y HuangM H Weir
Apr 17, 2009·Environmental Science & Technology·Phillip N PriceJennifer A McWilliams
May 12, 2009·Applied and Environmental Microbiology·Cheryl Fairfield EstillMatthew J Arduino
Aug 4, 2009·Applied and Environmental Microbiology·Amanda B HerzogSyed A Hashsham
May 1, 1987·Environmental Science & Technology·C C TravisE D Klema

❮ Previous
Next ❯

Citations

May 10, 2012·Environmental Science & Technology·Tao Hong, Patrick L Gurian
Dec 6, 2011·Applied and Environmental Microbiology·Paula A KrauterWayne Einfeld
Jun 12, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Elżbieta Anna TrafnyMiron Kaliszewski
Feb 18, 2016·Journal of Exposure Science & Environmental Epidemiology·Erin E SilvestriTonya L Nichols
Feb 19, 2016·Risk Analysis : an Official Publication of the Society for Risk Analysis·Bradford W GuttingBrandolyn Thran
Apr 21, 2012·Journal of Applied Microbiology·J Mitchell-BlackwoodB Thran
May 7, 2015·Risk Analysis : an Official Publication of the Society for Risk Analysis·Michael A HamiltonPatrick L Gurian
May 12, 2015·Environmental Science & Technology·Tao Hong, Patrick L Gurian
Sep 24, 2016·Journal of Applied Microbiology·S B TamrakarJ B Rose
May 17, 2017·Journal of Occupational and Environmental Hygiene·Sergey A GrinshpunLaura Rose
May 5, 2018·Microbial Biotechnology·Kyle S EngerDavid M Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Applied and Environmental Microbiology
Ryan SinclairCharles P Gerba
Risk Analysis : an Official Publication of the Society for Risk Analysis
Charles N Haas
Environmental Science & Technology
Phillip N PriceJennifer A McWilliams
© 2021 Meta ULC. All rights reserved